| Sarah E Casper, AGACNP-BC | |
|
701 E County Line Rd Ste 101, Greenwood, IN 46143-1070 | |
| (317) 885-2860 | |
| Not Available |
| Full Name | Sarah E Casper |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 701 E County Line Rd Ste 101, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588278709 | NPI | - | NPPES |
| 300045577 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Francis Medical Group Llc | 7012067697 | 112 |
News Archive
Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
› Verified 8 days ago
| Entity Name | Indiana Internal Medicine Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609834357 PECOS PAC ID: 7911899489 Enrollment ID: O20040329000685 |
News Archive
Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
› Verified 8 days ago
| Entity Name | St Francis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467693135 PECOS PAC ID: 7012067697 Enrollment ID: O20090603000310 |
News Archive
Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah E Casper, AGACNP-BC 701 E County Line Rd Ste 101, Greenwood, IN 46143-1070 Ph: (317) 885-3793 | Sarah E Casper, AGACNP-BC 701 E County Line Rd Ste 101, Greenwood, IN 46143-1070 Ph: (317) 885-2860 |
News Archive
Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."
Abbott (NYSE: ABT) announced today positive one-year clinical results from ABSORB Japan, a multi-center, randomized trial comparing the safety and effectiveness of Abbott's fully dissolving Absorb™ heart stent to XIENCE ®, Abbott's market-leading, permanent drug eluting stent.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
Frederick A. Gulmi, MD, chief of urology at NYU Lutheran, cautions anyone who has never had a bout with kidney stones.
› Verified 8 days ago
Marilyn Ann Jones, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2867 Bloomsbury S, Greenwood, IN 46143 Phone: 317-402-6341 | |
Patricia Justine Irvin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 700 Us Highway 31 S, Greenwood, IN 46143 Phone: 317-883-0567 | |
Laura Walradth, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1703 W Stones Crossing Rd Ste 200, Greenwood, IN 46143 Phone: 317-781-7188 Fax: 317-781-7140 | |
Meagan Lee Mcdurfee, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2355 Endress Pl Suite A, Greenwood, IN 46143 Phone: 317-530-1811 Fax: 317-963-1621 | |
Haleigh Ann Tharp, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 333 E County Line Rd Ste B, Greenwood, IN 46143 Phone: 317-497-6333 Fax: 317-497-6334 | |
Hannah E Mason, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Mrs. Cassie A Himes, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1703 W Stones Crossing Rd Ste 310, Greenwood, IN 46143 Phone: 317-887-6060 Fax: 317-859-5944 |